[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 23.23.54.109. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 5,148
Citations 0
Editorial
August 9, 2016

Lipid Screening in Children and Adolescents

Author Affiliations
  • 1Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  • 2Boston Children’s Hospital, Boston, Massachusetts
JAMA. 2016;316(6):589-591. doi:10.1001/jama.2016.9671

In this issue of JAMA, the US Preventive Services Task Force (USPSTF) releases its recommendations on lipid screening in children and adolescents,1 updating the 2007 recommendation on this topic.2 The 2016 recommendation statement is accompanied by 2 companion Evidence Reports on screening for detection of familial hypercholesterolemia (FH)3 and multifactorial dyslipidemia.4 The conclusion of the task force is unchanged from 2007: “The current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents younger than 20 years.”1 The purpose of this Editorial is to provide additional context for clinicians, policy makers, patients, and their families deciphering the meaning and implications of the “I” statement as they engage in their own informed health care decision making.

First Page Preview View Large
First page PDF preview
First page PDF preview
×